A 2022 meta-analysis published in Cardiovascular Diabetology examining GLP-1 receptor agonist effects on lipid profiles found that semaglutide and tirzepatide produced statistically significant reductions in triglycerides across all trials examined, with the magnitude of reduction correlating with both the degree of weight loss achieved and baseline triglyceride levels, supporting the clinical rationale for GLP-1 use in patients with hypertriglyceridemia alongside obesity
Analyses of patients included in Taxonomy cohort that did not receive adjuvant 5FU-based chemotherapy treatment
2.1.5 Polyphenols The antioxidant properties of dietary polyphenols, including phenolic acids, anthocyanins, flavanols, flavones, and proanthocyanidins, are being intensively researched
Comparative Mechanisms with Other Agents Compared with metformin, which improves insulin sensitivity primarily through hepatic and muscular pathways, GLP-1 RAs act centrally and peripherally to influence appetite, glucose metabolism, and systemic inflammation